Department of Cancer Biology and Genetics, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
Institute for Behavioral Medicine Research, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
Biomolecules. 2021 Jan 29;11(2):185. doi: 10.3390/biom11020185.
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) or Systemic Exertion Intolerance Disease (SEID) is a chronic multisystem illness of unconfirmed etiology. There are currently no biomarkers and/or signatures available to assist in the diagnosis of the syndrome and while numerous mechanisms have been hypothesized to explain the pathology of ME/CFS, the triggers and/or drivers remain unknown. Initial studies suggested a potential role of the human herpesviruses especially Epstein-Barr virus (EBV) in the disease process but inconsistent and conflicting data led to the erroneous suggestion that these viruses had no role in the syndrome. New studies using more advanced approaches have now demonstrated that specific proteins encoded by EBV could contribute to the immune and neurological abnormalities exhibited by a subgroup of patients with ME/CFS. Elucidating the role of these herpesvirus proteins in ME/CFS may lead to the identification of specific biomarkers and the development of novel therapeutics.
肌痛性脑脊髓炎/慢性疲劳综合征(ME/CFS)或全身性运动不耐受疾病(SEID)是一种病因未明的慢性多系统疾病。目前尚无生物标志物和/或特征可用于辅助诊断该综合征,虽然有许多机制被假设用于解释 ME/CFS 的病理学,但触发因素和/或驱动因素仍不清楚。最初的研究表明人类疱疹病毒,特别是 EBV(Epstein-Barr virus)在疾病过程中可能起作用,但不一致和相互矛盾的数据导致错误地认为这些病毒在该综合征中没有作用。现在,使用更先进方法的新研究表明,EBV 编码的特定蛋白可能导致 ME/CFS 亚组患者表现出免疫和神经异常。阐明这些疱疹病毒蛋白在 ME/CFS 中的作用可能会导致特定生物标志物的识别和新型治疗方法的开发。